Lifeward (LFWD) Profit After Tax Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.67% |
| Dec 31, 2025 | -12.67% |
| Sep 30, 2025 | 1.02% |
| Jun 30, 2025 | -18.11% |
| Mar 31, 2025 | -4.56% |
| Dec 31, 2024 | -33.71% |
| Sep 30, 2024 | 1.87% |
| Jun 30, 2024 | 1.27% |
| Mar 31, 2024 | -9.43% |
| Dec 31, 2023 | -2.36% |
| Sep 30, 2023 | -10.69% |
| Jun 30, 2023 | 4.35% |
| Mar 31, 2023 | 7.34% |
| Dec 31, 2022 | 2.92% |
| Sep 30, 2022 | 1.36% |
| Jun 30, 2022 | 6.76% |
| Mar 31, 2022 | 7.43% |
| Dec 31, 2021 | 14.70% |
| Sep 30, 2021 | 19.51% |
| Jun 30, 2021 | 19.19% |
| Mar 31, 2021 | 15.05% |
| Dec 31, 2020 | 17.07% |
| Sep 30, 2020 | 12.20% |
| Jun 30, 2020 | 13.24% |
| Mar 31, 2020 | 7.62% |
| Dec 31, 2019 | 8.22% |
| Sep 30, 2019 | -20.37% |
| Jun 30, 2019 | -24.39% |
| Dec 31, 2018 | -7.78% |
| Sep 30, 2018 | -6.72% |